RCHOP Chemoimmunotherapy Preceded BY BBB Permeabilization by t-NGR Necrosis Factor

Clinical trial NCT03536039 · COMPLETED

Trial details

NCT number: NCT03536039
Sponsor: Andres J. M. Ferreri
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Large B-Cell, Diffuse

Start date: 2016-01-27
Primary completion: 2019-01-27
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.